Enzyme Replacement Therapy Market Size, Share & Industry Analysis, By Drug Class (Alglucosidase alfa, Agalsidase, Pancrelipase, Idursulfase, Laronidase, Imiglucerase, Elosulfase alfa, Asfotasealfa, Galsulfase, Velaglucerase alfa, and Others), By Route of Administration (Parenteral and Oral), By Indication (Type 1 Gaucher Disease, Pompe Disease, MPS (Mucopolysaccharidosis), Exocrine Pancreatic Insufficiency (EPI), Fabry Disease, Hypophosphatasia, and Others), By End User (Hospitals and Homecare Settings & Infusion Centers), and Regional Forecast, 2024-2032
Last Updated: December 02, 2024 | Format: PDF | Report ID: FBI106424